Authentidate Holding Corp. has partnered with AEON Clinical Laboratories to launch Cancer Detect Profile , a 38-gene cancer genetic test coupled with telehealth-based genetic counseling for 6,000 prescribing physicians throughout the country. The test is designed to identify patients with increased risk of colorectal, breast, pancreatic, ovarian, gastric, melanoma, stomach and other cancers by analyzing mutations in their DNA and RNA within a panel of 38-genes associated with cancer.